| Ticker | Name | Price | 30-Day Trend | Pipeline | Segment | Valuation | Therapeutic Area | Market Capital | Volume | P/E RATIO | Insiders | EPS | D/E RATIO | Live-Cash | Burn Rate | Ebitda | Runway | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | Agilent Technologies, Inc. | 170.54 1.41 % | +10.9% | N/A (Dx) | Diagnostics | Diagnostics | 48.08 B | 1.54 M | 33.39 | -95.97 K | 5.11 | 0.49 | 1.76 B | - | 1.84 B | - | PROFITABLE | |
AAPG | Ascentage Pharma Group International - American Depository Shares | 14.75 1.37 % | -19.3% | Pharma Clinical | — | 1.38 B | 1.20 K | 0.00 | - | -1.94 | 1.50 | 171.93 M | 14.56 M | -156.72 M | 24.28 | — | ||
AARD | Aardvark Therapeutics, Inc. | 4.76 1.06 % | -17.8% | Pharma Clinical | — | 104.17 M | 140.86 K | 0.00 | -394.96 K | -3.19 | 0.00 | 73.87 M | 5.87 M | -74.68 M | 10.60 | CAUTION | ||
ABBV | AbbVie Inc. | 276.47 1.49 % | +8.2% | Pharma Commercial | — | Cardiovascular Disease, Dermat Read More | 488.47 B | 4.30 M | 77.43 | -10.76 M | 3.57 | 0.00 | 6.57 B | - | 29.19 B | - | PROFITABLE | |
ABCL | AbCellera Biologics Inc. | 12.545 4.24 % | +10.5% | Biotech Clinical | — | 3.85 B | 4.69 M | 0.00 | 1.55 M | -0.51 | 0.15 | 540.10 M | - | -181.09 M | - | PROFITABLE | ||
ABEO | Abeona Therapeutics Inc. | 4.94 -0.20 % | -16.6% | Pharma Commercial | — | 282.49 M | 1.28 M | 0.00 | -306.05 K | -1.10 | 0.16 | 146.83 M | 5.83 M | -89.14 M | 23.30 | STABLE | ||
ABOS | Acumen Pharmaceuticals, Inc. | 2.14 1.90 % | -26.7% | Biotech Clinical | — | 154.76 M | 357.54 K | 0.00 | - | -1.45 | 0.36 | 110.20 M | 6.03 M | -114.43 M | 16.30 | STABLE | ||
ABSI | Absci Corporation | 10.16 12.98 % | +16.6% | Biotech Clinical | — | 1.74 B | 4.25 M | 0.00 | - | -0.71 | 0.03 | 201.14 M | 9.19 M | -117.14 M | 19.90 | STABLE | ||
ABT | Abbott Laboratories | 99.6 1.13 % | -11.4% | MedTech Commercial | MedTech | Analgesia/Anesthesiology/Anti- Read More | 172.35 B | 6.96 M | 31.77 | -68.40 M | 3.14 | 0.65 | 5.60 B | - | 11.19 B | - | PROFITABLE | |
ABUS | Arbutus Biopharma Corporation | 4.22 0.96 % | -16.8% | Pharma Clinical | — | 836.01 M | 3.15 M | 5.46 | -2.48 M | 0.77 | 0.02 | 92.63 M | 2.01 M | 155.14 M | 44.20 | HEALTHY | ||
ABVC | ABVC BioPharma, Inc. | 1 2.04 % | +20.5% | Pharma Clinical | — | 26.65 M | 41.47 K | 0.00 | - | -0.27 | 0.25 | 94.36 K | 81.00 K | -7.55 M | 0.73 | CRITICAL | ||
ABVX | Abivax SA | 88.15 -1.64 % | -22.2% | Pharma Clinical | — | 7.70 B | 885.32 K | 0.00 | - | -5.25 | 0.08 | 606.82 M | 17.17 M | -300.56 M | 32.98 | — | ||
ACAD | ACADIA Pharmaceuticals Inc. | 19.78 1.79 % | -32.1% | Pharma Commercial | — | 3.41 B | 1.47 M | 8.96 | -1.38 M | 2.21 | 0.04 | 956.47 M | - | 92.71 M | - | PROFITABLE | ||
A ACB | Aurora Cannabis Inc. Common Shares | 4.49 -0.45 % | +12.0% | Pharma | — | 291.14 M | 1.35 M | 0.00 | - | -1.15 | NaN | - | - | - | NaN | — | ||
ACET | Adicet Bio, Inc. | 5.61 -2.26 % | -38.1% | Pharma Clinical | — | 52.52 M | 189.83 K | 0.00 | - | -10.57 | 0.10 | 118.19 M | 6.61 M | -107.78 M | 15.70 | STABLE | ||
ACH | Accendra Health, Inc. | 0.428 -3.43 % | -64.6% | — | — | — | 32.92 M | 681.11 K | 0.00 | - | -3.93 | 0.00 | 7.65 M | 8.67 M | 344.06 M | 34.61 | CRITICAL | |
A ACHC | Acadia Healthcare Company, Inc. | 29.25 2.70 % | +2.5% | — | — | — | 2.72 B | 1.38 M | 0.00 | - | -12.10 | NaN | 171.29 M | - | - | - | PROFITABLE | |
ACHV | Achieve Life Sciences, Inc. | 7.41 2.23 % | -8.5% | Biotech Clinical | — | 762.51 M | 987.30 K | 0.00 | -175.18 K | -1.53 | 1.40 | 187.30 M | 3.59 M | -52.23 M | 50.10 | HEALTHY | ||
ACIU | AC Immune SA | 2.5 -1.96 % | -5.7% | Pharma Clinical | — | 254.43 M | 271.32 K | 0.00 | - | -0.82 | 0.14 | 33.82 M | - | - | 0.00 | — | ||
A ACOG | Alpha Cognition Inc. | 9.04 0.00 % | -1.3% | — | — | 196.87 M | 20.35 K | 0.00 | 3.58 M | -1.08 | -2.72 | 41.38 M | 2.29 M | -11.45 M | 16.20 | STABLE | ||
A ACON | Aclarion, Inc. Common Stock | 2.34 1.30 % | -2.5% | N/A (Dx) | Diagnostics | Diagnostics | 6.74 M | 7.30 K | 0.00 | 125.67 K | -3.19 | NaN | 16.29 M | 886.00 K | - | 16.20 | STABLE | |
ACRS | Aclaris Therapeutics, Inc. | 3.83 4.22 % | -36.3% | Pharma Clinical | — | 535.53 M | 5.06 M | 0.00 | - | -0.51 | 0.01 | 170.62 M | 6.62 M | -77.86 M | 23.60 | STABLE | ||
ACRV | Acrivon Therapeutics, Inc. | 1.91 0.71 % | -7.3% | Pharma Clinical | — | 81.85 M | 192.04 K | 0.00 | -40.39 K | -1.73 | 0.03 | 89.96 M | 4.95 M | -81.01 M | 16.20 | STABLE | ||
ACTU | Actuate Therapeutics, Inc. | 0.6102 -8.69 % | -63.1% | Pharma Clinical | — | 14.65 M | 301.19 K | 0.00 | - | -0.85 | 0.11 | 4.43 M | 1.47 M | -21.83 M | 1.10 | CRITICAL | ||
ACXP | Acurx Pharmaceuticals, Inc. | 1.27 5.60 % | -11.8% | Pharma Clinical | — | Gastroenterology, Infectious D Read More | 7.06 M | 41.15 K | 0.00 | - | -1.75 | 0.00 | 10.66 M | 570.00 K | -7.63 M | 16.80 | STABLE | |
ADAG | Adagene Inc. | 2.76 -0.72 % | -25.0% | Pharma Clinical | — | 185.32 M | 1.65 M | 0.00 | 162.24 K | -0.37 | 0.12 | 74.52 M | 1.31 M | -20.91 M | 56.95 | — | ||
ADCT | ADC Therapeutics SA | 1.73 8.81 % | +51.8% | Pharma Commercial | — | 220.87 M | 3.14 M | 0.00 | - | -0.76 | 0.00 | 219.11 M | 3.94 M | -104.12 M | 53.80 | HEALTHY | ||
ADGM | Adagio Medical Holdings, Inc | 0.13 -0.08 % | -74.6% | N/A (Device) | MedTech | MedTech | 2.89 M | 690.43 K | 0.00 | - | -1.22 | 4.21 | 7.74 M | 1.75 M | -18.39 M | 2.40 | CRITICAL | |
ADIL | Adial Pharmaceuticals, Inc | 3.9 -1.76 % | -30.4% | Pharma Clinical | — | Analgesia/Anesthesiology/Anti- Read More | 10.24 M | 3.05 K | 0.00 | 8.69 K | -19.70 | 0.00 | 28.71 M | 2.12 M | -7.53 M | 11.60 | CAUTION | |
ADMA | ADMA Biologics Inc | 10.36 0.29 % | +10.9% | Biotech Commercial | — | Infectious Disease (viral), In Read More | 2.32 B | 2.83 M | 13.73 | - | 0.75 | 0.52 | 136.02 M | - | 214.82 M | - | PROFITABLE | |
ADPT | Adaptive Biotechnologies Corporation | 26.49 0.92 % | +5.2% | Pharma | — | 4.23 B | 1.53 M | 0.00 | -81.21 M | -0.40 | 0.96 | 371.74 M | 2.13 M | -28.80 M | 172.10 | HEALTHY | ||
A ADRX | ADARx Pharmaceuticals, Inc. Common Stock | 17.78 0.59 % | -8.1% | Pharma | — | 1.34 B | 688.46 K | NaN | 53.42 M | NaN | NaN | - | - | - | NaN | — | ||
A ADUS | Addus HomeCare Corp. | 114.33 0.06 % | -1.1% | — | — | — | 2.14 B | 172.78 K | 20.27 | - | 5.64 | NaN | 99.57 M | - | - | - | PROFITABLE | |
ADVB | Advanced Biomed Inc. | 5.31 -13.24 % | -45.3% | N/A (Dx) | Diagnostics | Diagnostics | 8.77 M | 8.80 K | 1.66 | - | 3.20 | 0.08 | 2.60 M | 80.00 K | -81.53 K | 27.60 | HEALTHY | |
ADXN | Addex Therapeutics Ltd | 3.2186 -5.03 % | -16.2% | Pharma Clinical | — | Analgesia/Anesthesiology/Anti- Read More | 5.86 M | 4.51 K | 0.00 | - | -9.10 | 0.01 | 2.07 M | 219.23 K | -3.40 M | 9.43 | — | |
AEMD | Aethlon Medical, Inc. | 6.05 1.83 % | +143.0% | N/A (Device) | MedTech | MedTech | 4.30 M | 15.18 K | 0.00 | - | -9.76 | 0.06 | 4.93 M | 632.00 K | -6.82 M | 5.90 | DISTRESSED | |
AEON | AEON Biopharma, Inc. | 0.276 -10.97 % | -12.2% | Pharma Clinical | — | 13.77 M | 1.63 M | 0.00 | 243.46 K | -1.09 | 0.00 | 3.43 M | 1.23 M | -18.81 M | 0.80 | CRITICAL | ||
AGEN | Agenus Inc. | 7.67 1.72 % | +0.1% | Biotech Clinical | — | 346.39 M | 710.29 K | 3.40 | - | 2.25 | 0.00 | 18.74 M | 10.40 M | 15.19 M | 4.80 | CRITICAL | ||
AGIO | Agios Pharmaceuticals, Inc. | 31.81 -0.34 % | -4.5% | Pharma Commercial | — | Endocrinology/Metabolism/Bone, Read More | 1.90 B | 835.68 K | 0.00 | -914.40 K | -6.89 | 0.03 | 964.83 M | 19.10 M | -470.27 M | 48.10 | HEALTHY | |
A AGL | agilon health, inc. | 82.39 -2.75 % | -11.0% | — | — | — | 1.38 B | 171.88 K | 0.00 | - | -13.83 | NaN | 185.63 M | 19.10 M | - | 7.50 | CAUTION | |
AGMB | AgomAb Therapeutics NV | 9.08 0.43 % | -31.1% | Biotech Clinical | — | 447.17 M | 102.31 K | 0.00 | 311.17 K | 0.00 | 0.01 | 101.49 M | - | - | 0.00 | — | ||
AGPU | Axe Compute Inc. | 11.68 4.65 % | +17.7% | N/A (Device) | MedTech | MedTech | 135.38 M | 143.37 K | 0.00 | 98.33 K | -21.87 | 0.04 | 21.91 M | - | -28.87 M | - | PROFITABLE | |
A AHCO | AdaptHealth Corp. Common Stock | 6.06 -0.08 % | +4.7% | — | — | — | 826.25 M | 1.46 M | 0.00 | 393.13 K | -1.71 | NaN | 43.29 M | - | - | - | PROFITABLE | |
A AHG | Akso Health Group ADS | 1.25 -0.88 % | +45.9% | — | — | — | 1.07 B | 21.14 K | 0.00 | - | -0.47 | NaN | - | - | - | NaN | — | |
A AIDX | 20/20 Biolabs, Inc. Common Stock | 0.375 5.54 % | -39.9% | — | — | — | 4.79 M | 65.82 K | 0.00 | - | 0.00 | NaN | 4.55 M | 202.00 K | - | 20.60 | STABLE | |
AIFF | Firefly Neuroscience, Inc. | 1.19 -2.60 % | +10.2% | — | — | — | 18.67 M | 101.01 K | 0.00 | - | -0.58 | 0.00 | 9.23 M | 583.00 K | -8.35 M | 13.80 | STABLE | |
AIM | AIM ImmunoTech Inc. | 0.18 0.22 % | -30.3% | Biotech Clinical | — | Infectious Disease (viral), On Read More | 7.05 M | 424.18 K | 0.00 | 13.46 K | -0.36 | 2.15 | 9.96 M | 1.53 M | -9.27 M | 4.40 | DISTRESSED | |
AIMD | Ainos, Inc. | 1.21 0.00 % | -14.2% | Biotech Clinical | — | 8.93 M | 17.61 K | 0.00 | - | -1.96 | 0.96 | 1.42 M | 483.00 K | -9.81 M | 0.60 | CRITICAL | ||
AIRS | AirSculpt Technologies, Inc. | 1.62 -2.11 % | -37.7% | — | — | — | 116.79 M | 1.02 M | 0.00 | - | -0.16 | 0.72 | 18.82 M | 413.00 K | 12.42 M | 43.60 | HEALTHY | |
A AKAN | Akanda Corp. Common Shares | 1.76 -2.25 % | -54.8% | Pharma | — | 951.88 K | 65.22 K | 0.00 | - | 0.00 | NaN | - | - | - | NaN | — |